Vagal atrial fibrillation: What is it and should we treat it?

A Carpenter, A Frontera, R Bond, E Duncan… - International journal of …, 2015 - Elsevier
Vagal atrial fibrillation (AF) remains an under-recognised entity, affecting younger patients
often with structurally normal hearts. Although there remains no universal definition or …

Vagal atrial fibrillation: What is it and should we treat it?

A Carpenter, A Frontera, R Bond, E Duncan… - International Journal of …, 2015 - infona.pl
Vagal atrial fibrillation (AF) remains an under-recognised entity, affecting younger patients
often with structurally normal hearts. Although there remains no universal definition or …

Vagal atrial fibrillation: What is it and should we treat it?

A Carpenter, A Frontera, R Bond… - International …, 2015 - pubmed.ncbi.nlm.nih.gov
Vagal atrial fibrillation (AF) remains an under-recognised entity, affecting younger patients
often with structurally normal hearts. Although there remains no universal definition or …

[引用][C] Vagal atrial fibrillation: What is it and should we treat it?

A Carpenter, A Frontera, R Bond, E Duncan… - International Journal of …, 2015 - cir.nii.ac.jp

Vagal atrial fibrillation: What is it and should we treat it?

A Carpenter, A Frontera, R Bond, E Duncan… - International Journal of …, 2015 - hero.epa.gov
Vagal atrial fibrillation (AF) remains an under-recognised entity, affecting younger patients
often with structurally normal hearts. Although there remains no universal definition or …

Vagal atrial fibrillation: What is it and should we treat it?

A Carpenter, A Frontera… - International …, 2015 - internationaljournalofcardiology.com
Vagal atrial fibrillation (AF) remains an under-recognised entity, affecting younger patients
often with structurally normal hearts. Although there remains no universal definition or …

Vagal atrial fibrillation: What is it and should we treat it?

A Carpenter, A Frontera, R Bond, E Duncan… - … Journal of Cardiology, 2015 - europepmc.org
Vagal atrial fibrillation (AF) remains an under-recognised entity, affecting younger patients
often with structurally normal hearts. Although there remains no universal definition or …